91ÊÓƵ

Spiro is responsible for the overall strategy, implementation, and growth of 91ÊÓƵ’s U.S. Generics Business.

Prior to joining 91ÊÓƵ, he gained comprehensive pharma, injectables and biotech experience, most notably serving as the President, Specialty Generics at Mallinckrodt Pharmaceuticals and President, US Injectables at Hikma.

Spiro holds a Bachelor’s degree from Franklin & Marshall College and MBA from New York University Stern School of Business.